10262 - The Role of Lipid Apheresis in Focal Segmental Glomerulosclerosis (FSGS) Treatment

Course Directors

Joshua Zaritsky, M.D., Ph.D., St. Christopher's Hospital for Children
Tarek Alhamad, M.D., Washington University School of Medicine in St. Louis


This course reviews current treatments of focal segmental glomerulosclerosis with particular attention to lipid apheresis. Learn how lipid apheresis is a novel and potentially transformative therapy for this otherwise difficult to treat disease.


AMA PRA Category 1 Credits™

Opus Medicus designates this Internet enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Credits

In addition to AMA PRA Category 1 Credits™, Opus Medicus designates this course for Specialty Board MOC Program Credits:

1.0 ABIM MOC Points1

Accreditation Statement

Opus Medicus is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Tuition Fees

Course & Credits: Free

Course Dates

Offered Date: 23-Feb-2022
Expiration Date: 22-Feb-2025


After taking this course participants will have a greater understanding of:

1. The epidemiology and clinical attributes of focal segmental glomerulosclerosis (FSGS).

2. Poor results of available drug options to treat FSGS.

3. Lipid apheresis - mechanism and efficacy as a treatment for FSGS.


1. Pathophysiology of FSGS.

2. Clinical features of FSGS.

3. Treatment options for FSGS.

4. Lipid apheresis as a treatment for FSGS.

American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Education (ACGME) Competencies

☑  Patient Care (PC)
☑  Medical Knowledge (MK)

Financial Relationship Disclosure and Content Attestation

Dr. Joshua Zaritsky, course director, attest that he has no financial relationships with a commercial entity offering healthcare related products and/or services. Dr. Tarek Alhamad, moderator, discloses that he has had research grants with Kaneka and Mallinckrodt. He attests that none of these entities have had an influence on the course content. Dr. Paul VanderLaan, reviewer, discloses that he has consulted in an advisory capacity for Gala Therapeutics, Caris Life Sciences, Foundation Medicine, Flatiron Health, Intuitive Surgical, and Clearview Healthcare Partners. He attests that none of these entities have had an influence on the course content or his review thereof. Dr. Steven R. Tahan, Education Committee Chair, attests that he has no financial relationships with a commercial entity offering healthcare related products and/or services. No other person who has provided content for or who can influence the content of this course has disclosed financial relationships with commercial entities that offer healthcare-related products or services relevant to the course content. Financial support for this course has been received from Kaneka Pharma America, LLC, which has had no influence on the course content.

Supported Computer Hardware and Software Configurations2

Supported client computing platforms include:

A broadband Internet connection is required (e.g., cable, DSL, and 3G or 4G wireless). The course presentation is automatically scaled to the size of the display, from 800x480 pixels (minimum supported) to 1920x1200 pixels. On some smart phones, viewing courses may be tedious.

Supported browsers include:

Javascript, cookies, and popups must be enabled on your browser (which is the default configuration for most browsers).

1. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points for the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) Program, in addition to AMA PRA Category 1 Credits™. Participants will earn MOC points equivalent to the amount of AMA PRA Category 1 credits claimed for the activity. Immediately upon course completion, Opus Medicus will submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

2. The course may also be viewable on other client computing platforms that comply with Internet standards. If you experience technical problems that prevent you from viewing the course, we will promptly issue a full refund upon request.